Tom Spencer

JULY 14, 2018

Because of the ability of health insurance companies and benefit executives at leading pharmaceutical companies to negotiate discounts and benefit packages, many in the industry argue that list prices on prescription drugs aren’t actually a reliable indicator of what Americans pay. From 2010 to 2015, prescription medicine revenue in the U.S.

Pharmaceuticals 79

Pharmaceuticals Government Healthcare Sales 79

Tom Spencer

AUGUST 17, 2019

years ago my touchpoints with blockchain increased, for example, while writing my master degree thesis on “Possible Applications on Health Data and Health Insurance” I interviewed someone in the health space that was working on a blockchain project for his health data startup.

Case Interview 60

Case Interview Retail Examples Sales 60

Harvard Business

NOVEMBER 12, 2018

In a recent Goldman Sachs research report about the promise of gene therapies, analysts asked a question that gets to the heart of a growing dilemma for the healthcare sector: “Is curing patients a sustainable business model?” But there was a catch: the one-time treatment, Luxturna from Spark Therapeutics, costs $850,000.

Insurance 38

Insurance Insurance Healthcare System 38